May 18, 2017 8:00 am EDT Acasti Pharma Presents CaPre Clinical Data at National Lipid Association Scientific Sessions
Apr 24, 2017 8:00 am EDT Acasti Granted Additional Composition & Use Patents in Taiwan and Australia; Safeguards Valuable Market Expansion Opportunities
Apr 12, 2017 8:00 am EDT Acasti Pharma to Present CaPre Omega-3 Bridging Study Results at National Lipid Association Scientific Sessions
Mar 8, 2017 8:00 am EST Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts
Feb 2, 2017 11:31 am EST Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units